Physician profile
John Kim
NPI 1811928245
$3,489.11
in general payments reported to CMS, 2019-2025
29 companies · $703 in 2025
The $703 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $178 · 2021: $397 · 2022: $631 · 2023: $385 · 2024: $599 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $552.54 | 2019-2025 | Clareon, Hydrus Microstent, Rocklatan |
| Abbvie INC. | $499.43 | 2023-2025 | |
| Glaukos Corporation | $380.44 | 2019-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Sight Sciences, INC. | $358.72 | 2019-2024 | Omni Surgical System |
| Ivantis, INC | $232.63 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $204.99 | 2019-2025 | Tecnis Iol, Veritas Vision System |
| Carl Zeiss Meditec USA, INC. | $151.66 | 2022-2023 | Artevo 800 |
| Allergan, INC. | $146.58 | 2020-2022 | |
| Biotissue Holdings INC. | $131.34 | 2023-2024 | |
| Medtronic, INC. | $117.19 | 2025 | Unid_pass |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.93 | 2019 | |
| Mallinckrodt Hospital Products INC. | $94.15 | 2022-2025 | Acthar |
| Coopervision INC. | $87.70 | 2019 | |
| Rxsight INC | $81.42 | 2022 | |
| Sun Pharmaceutical Industries INC. | $47.65 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iridex Corporation | $31.67 | 2023 | |
| Aerie Pharmaceuticals, INC. | $30.96 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $29.83 | 2021-2022 | |
| Oyster Point Pharma, INC. | $24.34 | 2023 | Tyrvaya |
| Bausch & Lomb Americas INC. | $22.92 | 2022 | |
| Genentech USA, INC. | $21.54 | 2023 | Vabysmo |
| Mallinckrodt Enterprises LLC | $21.16 | 2019 | |
| Dompe US, INC. | $20.03 | 2024 | Oxervate |
| Ani Pharmaceuticals, INC. | $19.47 | 2025 | Purified Cortrophin Gel |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $17.14 | 2024 | Xdemvy |
| New World Medical,INC. | $15.88 | 2022 | |
| Beaver-Visitec International, INC. | $15.52 | 2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.